GRTX · ISSUER CIK 1563577
Galera Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 4 Galera Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗4 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Aug 5, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 202617:16 | Aug 3, 2026 | GRTX | President and CEO, Director | D · To issuer | — | −975 | 0 | -100% | — | ||
| Aug 5, 202616:23 | Aug 3, 2026 | GRTX | Director, 10% Owner | D · To issuer | — | −47,434 | 0 | -100% | — | ||
| Aug 5, 202616:23 | May 15, 2026 | GRTX | Director, 10% Owner | C · ConvertLate 82d | — | +661,309 | 9,486,852 | +7% | — | ||
| Aug 5, 202616:22 | Aug 3, 2026 | GRTX | Director | D · To issuer | — | −51 | 0 | -100% | — | ||
| Aug 5, 202616:17 | Aug 3, 2026 | GRTX | Director | D · To issuer | — | −41,631 | 0 | -100% | — | ||
| Aug 5, 202616:17 | May 15, 2026 | GRTX | Director | C · ConvertLate 82d | — | +2,989,399 | 8,326,269 | +56% | — |